Scholar Rock Holding Corp
SRRKHealthcare|Biotechnology|USA
$56.75
-1.26 (-2.17%)
Tangible Book
$2.32
Earnings Power
$2.96
About
Scholar Rock Holding Corp is a biopharmaceutical company focused on improving the lives of children and adults with Spinal Muscular Atrophy and other rare, severe, and debilitating neuromuscular diseases. Its pipeline candidates include apitegromab and a subcutaneous formulation of apitegromab. The clinical-stage pipeline also includes SRK-439, an investigational subcutaneously administered fully human anti-pro/latent myostatin antibody with high inhibitory potency and selectivity toward myostatin, being developed for the treatment of rare neuromuscular diseases. The company also maintains early-stage programs focused on therapies for rare, severe, and debilitating neuromuscular diseases.
Stock Price
+48.9%(1Y)
Pipeline Summary
10 total trials2
Phase 1
4
Phase 2
2
Phase 3
0
Phase 4
NOT_YET_RECRUITING: 1Completed: 4NO_LONGER_AVAILABLE: 1Active: 2Recruiting: 2
Active Trials (4)
Long-Term Safety & Efficacy of Apitegromab in Patients With SMA Who Completed Previous Trials of Apitegromab
NCT05626855Spinal Muscular Atrophy
Phase 3Active
Enrollment: 238 participants
A Study to Evaluate How Apitegromab Works in Subjects Who Are Less Than 2 Years Old and Have Spinal Muscular Atrophy
NCT07047144Spinal Muscular Atrophy
Phase 2Recruiting
Enrollment: 52 participants
Acceptability, Feasibility, Safety and Efficacy of a Optimized Rehabilitation Program for Treated Patients With Spinal Muscular Atrophy (SMA).
NCT06419322Spinal Muscular Atrophy
N/AActive
Enrollment: 14 participants
A Single- and Multiple-Ascending Dose Study of SRK-439 in Healthy Adults
NCT07444294Healthy
Phase 1Recruiting
Enrollment: 76 participants
BioScore
4.9/10
Cautious
Ownership
Recent Insider Trades
Peng KatieSELL
2026-07-015,446 shares @ $53.88
FLIER JEFFREY S.SELL
2026-07-013,053 shares @ $53.88
Gilman MichaelSELL
2026-07-012,544 shares @ $53.87
Burow KristinaSELL
2026-07-013,053 shares @ $53.74
Reed JoshuaSELL
2026-07-013,053 shares @ $53.74
Recent News
2026-06-22 13:00:16
2026-06-12 21:00:06
Data last updated: Jul 12, 2026, 07:38 PM